EIF3K / EIF3S12 antibody
Principal name
EIF3K / EIF3S12 antibody
Alternative names for EIF3K / EIF3S12 antibody
Eukaryotic translation initiation factor 3 subunit K, eIF-3 p25, eIF-3 p28, PLAC-24, Muscle-specific gene M9 protein, Eukaryotic translation initiation factor 3 subunit 12
Ncbi ID
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF)
Background of EIF3K / EIF3S12 antibody
- Kit Component:
- - KN203529G1, EIF3K gRNA vector 1 in pCas-Guide vector
- KN203529G2, EIF3K gRNA vector 2 in pCas-Guide vector
- KN203529D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Mayeur G.L., et al. (2003). Eur. J. Biochem, 270: 4133-4139.
Wei Z., et al. (2004). J. Biol. Chem. 279: 34983-34990.
EIF3K Antibody (C-term) (Cat. #AP51398PU-N) western blot analysis in T47D cell line lysates (35µg/lane).This demonstrates the EIF3K antibody detected the EIF3K protein (arrow).
Recombinant human EIF3K, 1-218aa, His-tagged
Western blot analysis of EIF3K expression in SHSY5Y (A); HEK293T (B) whole cell lysates.
Sample (30 ug of whole cell lysate). A: H1299. 12% SDS PAGE. TA308505 diluted at 1:1000.
EIF3K antibody [N1C2] detects EIF3K protein at cytoplasm and nucleus by immunofluorescent analysis. Sample: HeLa cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: EIF3K protein stained by EIF3K antibody [N1C2] (TA308505) diluted at 1:500. B
Western blot analysis of extracts from HeLa cells, using EIF3K antibody.The lane on the right is treated with the synthesized peptide.
- Quick-Filters:
- Cited (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| AP51398PU-N | EIF3K / EIF3S12 (C-term) antibody |
||||||
 |
Rabbit | Ig | Aff - Purified | Hu | WB |
0.4 ml /
€415.00
|
|
| OriGene Technologies GmbH | |||||||
Published recently! |
|||||||
| TA308505 | EIF3K / EIF3S12 antibody |
||||||
| Rabbit polyclonal antibody to eIF3K (eukaryotic translation initiation factor 3, subunit K) | |||||||
 |
Rabbit | IgG | Aff - Purified | Hu | ICC/IF, WB |
0.1 ml /
€415.00
|
|
| OriGene Technologies, Inc. | |||||||
 +1 additional image |
|||||||
| TA312740 | EIF3K / EIF3S12 antibody |
||||||
| Rabbit polyclonal anti-EIF3K antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP303529 | EIF3K / EIF3S12 |
||||
| Recombinant protein of human eukaryotic translation initiation factor 3, subunit K (EIF3K) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| AR09912PU-L | EIF3K / EIF3S12 (1-218, His-tag) |
||||
 |
Human | Purified | > 95 % | E. coli |
0.25 mg /
€820.00
|
| OriGene Technologies GmbH | |||||
| +1 additional image |
|||||
| AR09912PU-N | EIF3K / EIF3S12 (1-218, His-tag) |
||||
|
Human | Purified | > 95 % | E. coli |
50 µg /
€320.00
|
| OriGene Technologies GmbH | |||||
| +1 additional image |
|||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY415721 | EIF3K overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR202466L2V | Lenti ORF particles, Eif3k (GFP-tagged) - Mouse eukaryotic translation initiation factor 3, subunit K (Eif3k), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR202466L1V | Lenti ORF particles, Eif3k (Myc-DDK-tagged) - Mouse eukaryotic translation initiation factor 3, subunit K (Eif3k), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
